SCHEMBL5728772

SCHEMBL5728772

COc1ccccc1-c1cc(Nc2ccc(CC(C)(C)C(N)=O)cc2)ncn1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.63
ALDH1A1 P00352 1/20 0.63
LMNA P02545 1/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2D6 P10635 1/20 0.63
ALOX15 P16050 1/20 0.63
CYP2C19 P33261 1/20 0.63
HSD17B10 Q99714 1/20 0.63
CLK4 Q9HAZ1 1/20 0.63
CCNT1 O60563 19/20 0.62
CDK9 P50750 19/20 0.62
MAP4K4 O95819 2/20 0.57
CDK1 P06493 2/20 0.57
CDK4 P11802 2/20 0.57
CCNB1 P14635 2/20 0.57
CCND1 P24385 2/20 0.57
ABL2 P42684 2/20 0.57
GSK3A P49840 2/20 0.57
CDK7 P50613 2/20 0.57
CCNH P51946 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4108860 0.86 CYP1A2 (0.48) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4116169 0.86 CYP1A2 (0.51) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4098423 0.83 ALDH1A1 (0.68) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4101911 0.83 USP2 (0.71) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4104588 0.81 USP2 (0.79) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4104601 0.81 USP2 (0.68) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4114595 0.81 ALDH1A1 (0.71) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4097323 0.81 USP2 (0.64) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL4098780 0.81 USP2 (0.67) USP2ALDH1A1LMNACYP1A2CYP2D6
SCHEMBL2997322 0.81 CDK9 (0.81) USP2ALDH1A1LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678147-A1 PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES GPC Biotech AG (DE) 2006-07-12 EP claimed
WO-2005026129-A1 PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES GPC BIOTECH AG (DE) 2005-03-24 WO claimed